Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction

Nephrology

Volumn 16, Issue 2, 2011, Pages 200-210

  Yuan, Xiao Peng ^a   He, Xiao Shun ^a   Wang, Chang Xi ^a   Liu, Long Shan ^a   Fu, Qian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

macrophages; mycophenolate mofetil; myofibroblast; renal fibrosis; triptolide; unilateral ureteral obstruction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1; TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY; KIDNEY FIBROSIS; MACROPHAGE; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SHAM PROCEDURE; SIRIUS RED STAINING; STAINING; URETER OBSTRUCTION;

ACTINS; ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINE CCL2; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DITERPENES; EPOXY COMPOUNDS; FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MACROPHAGE ACTIVATION; MALE; OSTEOPONTIN; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 79551572820     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01359.x     Document Type: Article

References (31)

1. Razzaque MS, Taguchi T,. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med. Electron Microsc. 2002; 35: 68-80.
2. Tao X, Lipsky PE,. The chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum. Dis. Clin. North Am. 2000; 26: 29-50, viii.
3. Li LS,. [clinical and experimental studies on the effect of Tripterygium wilfordii Hook in the treatment of nephritis]. Zhonghua Yi Xue Za Zhi 1982; 62: 581-5.
4. Li LS,. An overview of nephrology in china. Chin. Med. J. (Engl) 1989; 102: 488-95.
5. Ao JH, Li YT, Xiao XR,. [clinical study on the use of multiglycosides of Tripterygium wilfordii after cadaveric kidney transplantation]. Zhonghua Wai Ke Za Zhi 1994; 32: 175-7.
6. Wang J, Xu R, Jin R, Chen Z, Fidler JM,. Immunosuppressive activity of the chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000; 70: 447-55.
7. Ji SM, Wang QW, Chen JS, Sha GZ, Liu ZH, Li LS,. Clinical trial of Tripterygium wilfordii Hook F. In human kidney transplantation in China. Transplant. Proc. 2006; 38: 1274-9.
8. Gu WZ, Chen R, Brandwein S, McAlpine J, Burres N,. Isolation, purification, and characterization of immunosuppressive compounds from Tripterygium: triptolide and tripdiolide. Int. J. Immunopharmacol. 1995; 17: 351-6.
9. Ma J, Dey M, Yang H, et al. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 2007; 68: 1172-8.
10. Tao X, Cai JJ, Lipsky PE,. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F. J. Pharmacol. Exp. Ther. 1995; 272: 1305-12.
11. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S,. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am. J. Physiol. Renal Physiol. 2001; 280: F777-85.
12. Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH, Tang MJ,. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 2006; 69: 2029-36.
13. Zhang C, Zhu Z, Wang G, Deng A,. Effects of mycophenolate mofetil on renal interstitial fibrosis after unilateral ureteral obstruction in rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 2003; 23: 269-70, 282.
14. Goncalves RG, Biato MA, Colosimo RD, et al. Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats. Am. J. Nephrol. 2004; 24: 527-36.
15. Grimm PC, Nickerson P, Gough J, et al. Computerized image analysis of sirius red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J. Am. Soc. Nephrol. 2003; 14: 1662-8.
16. Demirbilek S, Emre MH, Aydin EN, et al. Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction. Pediatr. Nephrol. 2007; 22: 804-12.
17. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45.
18. Liu Y, Chen Y, Lamb JR, Tam PK,. Triptolide, a component of Chinese herbal medicine, modulates the functional phenotype of dendritic cells. Transplantation 2007; 84: 1517-26.
19. Lin N, Liu C, Xiao C, et al. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem. Pharmacol. 2007; 73: 136-46.
20. Krishna G, Liu K, Shigemitsu H, Gao M, Raffin TA, Rosen GD,. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am. J. Pathol. 2001; 158: 997-1004.
21. Kusunoki N, Yamazaki R, Kitasato H, Beppu M, Aoki H, Kawai S,. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol. 2004; 4: 2.
22. Hachida M, Lu H, Zhang X, et al. Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation. Transplant. Proc. 1999; 31: 2719-23.
23. Leonard CT, Soccal PM, Berry GJ, et al. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model. J. Heart Lung Transplant. 2002; 21: 1314-18.
24. Strutz F, Muller GA,. Renal fibrosis and the origin of the renal fibroblast. Nephrol. Dial. Transplant. 2006; 21: 3368-70.
25. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG,. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002; 110: 341-50.
26. Yang J, Liu Y,. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 2001; 159: 1465-75.
27. Qi W, Chen X, Poronnik P, Pollock CA,. Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int. J. Biochem. Cell Biol. 2008; 40: 9-13.
28. Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 2004; 165: 237-46.
29. Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J. Am. Soc. Nephrol. 2004; 15: 940-8.
30. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME,. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int. 2003; 63: 543-53.
31. Yoo KH, Thornhill BA, Forbes MS, et al. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int. 2006; 70: 1735-41.